Passive Cutaneous Anaphylaxis
|
phenotype |
|
Laboratory Procedure
|
1
|
|
0.300 |
limited |
1.000 |
1 |
|
2009 |
2009 |
Patent Ductus Venosus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
OBESITY, MODIFIER OF
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
BODY MASS INDEX, MODIFIER OF
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
INTIMAL MEDIAL THICKNESS OF INTERNAL CAROTID ARTERY, MODIFIER OF
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Carotid Intimal Medial Thickness 1
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1
|
|
0.500 |
None |
|
0 |
|
|
|
DIABETES MELLITUS, NONINSULIN-DEPENDENT, MODIFIER OF
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Increased carotid artery intimal medial thickness
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
cardiovascular problem
|
phenotype |
|
Sign or Symptom
|
2
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leishmania mexicana disease
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Chronic metabolic disorder
|
group |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
INSULIN RESISTANCE, SEVERE, DIGENIC
|
phenotype |
|
Finding
|
2
|
|
0.300 |
strong |
|
0 |
|
|
|
Chronobiology Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Inappropriate ACTH Secretion Syndrome
|
disease |
Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Psychogenic Inversion of Circadian Rhythm
|
disease |
Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
3
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Lipodystrophy, not elsewhere classified
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
4
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Non-intestinal type adenocarcinoma
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Marked muscular hypertrophy
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Loss of gluteal subcutaneous adipose tissue
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Prominent veins on trunk
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
Body Temperature Changes
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
6
|
1
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Loss of facial adipose tissue
|
phenotype |
|
Finding
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Leydig cell hyperplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
7
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
DEAFNESS-HYPOGONADISM SYNDROME
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Endocrine System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Thyroid associated orbitopathy
|
disease |
|
Disease or Syndrome
|
7
|
4
|
0.010 |
None |
1.000 |
1 |
2
|
2009 |
2009 |